Abiopharma

Press Release: AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Riverstone Holdings Limited - Announcement

Duolingo Invests in World-Class Motion Design with Acquisition of Animade

Okeanis Eco Tankers Corp. – Ex Dividend Date

SION ALERT: Investigation Launched into Sionna Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

Northern Trust Expands Relationship with First Sentier Group to Support Singapore Unit Trust Offering

Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update

Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants